Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
Internet Posting of Information Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at The Company encourages investors and potential investors to consult the Treace website regularly for important information about Treace.
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present at the 43(rd) Annual J.P. Morgan Healthcare Conference on Tuesday,
Zacks.com on MSN20h
Reasons to Retain Inari Medical Stock in Your Portfolio for NowInari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its ...
US-based medical device company Inari Medical has signed a joint venture deal with life sciences venture fund 6 Capital, successor fund 120 Capital, and China-based medical device platform ...
Inari Medical (NARI) announced it has entered into a joint venture with 6 Dimensions Capital and its successor fund 120 Capital, and VFLO Medical, or VFLO, a medical device platform incubated ...
Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback